Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019693 (
HIV
)
170,526
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
HIV
-specific CD8(+) T cells are prone to undergo apoptosis, and this may affect their ability to control
HIV infection
. Because CD8-mediated immune responses play a key role in controlling
HIV infection
, enhancing the survival and effector function of
HIV
-specific CD8(+) T cells may augment their ability to control
HIV
virus. We show here that
interleukin 15
(
IL-15
) potently inhibits spontaneous and CD95/Fas-induced apoptosis of
HIV
-specific CD8(+) T cells.
IL-15
inhibits apoptosis in both CD45RA(-)CD62L(-) and CD45RA(+)CD62L(-) effector memory subpopulations of these cells. Furthermore,
IL-15
greatly enhances the survival of
HIV
-specific CD8(+) T cells in long-term cultures. Finally,
IL-15
directly enhances activation, interferon gamma (IFNgamma) production, and direct ex vivo cytotoxicity of
HIV
-specific CD8(+) T cells. Thus,
IL-15
potently enhances the survival and effector function of
HIV
-specific CD8(+) T cells and, therefore, may prove useful in augmenting the antiviral function of these cells.
...
PMID:IL-15 enhances survival and function of HIV-specific CD8+ T cells. 1239 88
Virus-specific CD8(+) T-cell responses play a pivotal role in limiting viral replication. Alterations in these responses, such as decreased cytolytic function, inappropriate maturation, and limited proliferative ability could reduce their ability to control viral replication. Here, we report on the capacity of
HIV
-specific CD8(+) T cells to secrete cytokines and proliferate in response to
HIV
antigen stimulation. We find that a large proportion of
HIV
-specific CD8(+) T cells that produce cytokines in response to cognate antigen are unable to divide and die during a 48-hour in vitro culture. This lack of proliferative ability of
HIV
-specific CD8(+) T cells is defined by surface expression of CD57 but not by absence of CD28 or CCR7. This inability to proliferate in response to antigen cannot be overcome by exogenous interleukin-2 (IL-2) or
IL-15
. Furthermore, CD57 expression on CD8(+) T cells, CD4(+) T cells, and NK cells is a general marker of proliferative inability, a history of more cell divisions, and short telomeres. We suggest, therefore, that the increase in CD57(+)
HIV
-specific CD8(+) T cells results from chronic antigen stimulation that is a hallmark of
HIV infection
. Thus, our studies define a phenotype associated with replicative senescence in
HIV
-specific CD8(+) T cells, which may have broad implications to other conditions associated with chronic antigenic stimulation.
...
PMID:Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. 1243 88
Although the effect of
IL-15
has been described on murine cells in vitro and in vivo, its effect on human memory CD8(+) T cells is not well characterized. We show here that
IL-15
preferentially enhances the activation and effector function of human effector-memory CD45RA(-)CD62L(-) and CD45RA(+)CD62L(-) CD4(+) and CD8(+) T cells in both healthy and
HIV
-infected individuals. We find that
IL-15
increases 2- to 5-fold both the activation and secretion of the effector cytokines IFN-gamma and tumor necrosis factor (TNF)-alpha by anti-CD3-stimulated purified CD4(+) and CD8(+) T cells and peripheral blood mononuclear cells from healthy and
HIV
-infected individuals. Furthermore,
IL-15
potently inhibits CD95/Fas-induced apoptosis of the effector-memory CD4(+) and CD8(+) T cells from
HIV
-infected individuals. These findings suggest that in addition to being a growth and survival factor for memory CD8(+) T cells,
IL-15
is also a potent activator of human effector-memory CD8(+) T cells both in healthy and in
HIV
-infected individuals.
...
PMID:IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells. 1250 25
We investigated the effects of human immunodeficiency type-1 virus (
HIV
-1) matrix protein p17 on freshly isolated and purified human natural killer (NK) cells.
HIV
-1 p17 increased the cytokines interleukin (IL) 2, IL-12 and
IL-15
, and induced natural killer cell proliferation, but not cytotoxicity. This effect was specific because it was abrogated by anti-p17 monoclonal antibody. Moreover,
HIV
-1 p17 enhanced the cytokine-induced production of tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma by NK cells. IL-4 downregulated IFN-gamma and TNF-alpha secretion in IL-2- and
IL-15
-treated NK cells.
HIV
-1 p17 restored the ability of NK cells to produce both cytokines when added to the cultures simultaneously with IL-4. The property of p17 to increase the production of TNF-alpha and IFN-gamma might be a mechanism used by
HIV
-1 to modulate the immune system to support its replication and spreading.
...
PMID:HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines. 1254 96
We studied the effects of first generation
HIV
-1 plasmid vaccines in 167 individuals. The vaccines were very well tolerated and induced helper T cell responses in most vaccine recipients. However, the CTL responses were below a 20% response rate. Improvement in vaccine potency is an important goal of this technology and a central focus of our laboratory. To improve on these response rates, we used RNA optimized constructs pGag and pEnv). These vaccines express 20-100 fold better than first generation vectors. However, our studies support that additional enhancements are needed to further boost the immune response. We report that we can significantly enhance the induced CD8 effector cell response by including engineered B7 costimulatory molecules. We observed that B7.2 was more effective at driving cellular immune responses than B7.1 as a plasmid vaccine. We developed gene swaps and deletions between these two molecules. This manipulation resulted in a dramatically enhanced cellular immune response as measured by CTL, or ICC or Elispot. We have also explored the use of cytokines as plasmid vaccine adjuvants. We observed that IL-12 and
IL-15
were effective as plasmid vaccine adjuvants. Interestingly,
IL-15
appeared to allow T cell expansion in the absence of significant T cell help. Improvement of the immune response induced by plasmid vaccines can be engineered in multiple ways. Our studies show that both costimulation as well as cytokine signals can be harnessed for more potent vaccine development. These results have important implications for the design of vaccines for prophylaxis and therapy.
...
PMID:Next generation DNA vaccines for HIV-1. 1260 47
Vaccine efficacy is determined largely by cellular and humoral immunity as well as long-lasting immunological memory. IL-2 and
IL-15
were evaluated in vaccinia vectors expressing
HIV
gp160 for the establishment of an effective vaccine strategy. Both IL-2 and
IL-15
in the vaccinia vector induced strong and long-lasting antibody-mediated immunity as well as a short-term cytotoxic T cell response against
HIV
gp120. In addition,
IL-15
also supported robust CD8+ T cell-mediated long-term immunity, whereas the CD8+ T cell-mediated immunity induced by IL-2 was short-lived. Moreover, we found that the cytokine milieu at the time of priming had surprisingly persistent effects on the character of the memory CD8 T cells long afterward with respect to their fate, functional activities, cytokine receptor expression, and antigen-independent proliferation.
...
PMID:Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. 1262 40
Cellular immune responses play a central role in controlling
HIV
-1 infection.
HIV
-specific IFN-gamma production by CD8 T cells was evaluated in 17 HLA-A2+
HIV
-infected pediatric patients (age range 1 month to 16 years) in an ELISPOT assay. Most patients (15/17) exhibited responses to
HIV
-gag, followed by responses to envelope gp120, gp41, and V3 loop. Only 7 patients responded to all four antigenic peptides. Treatment-related immune reconstitution of CD4 T cells was associated with increase in gag-specific responses, but these declined with prolonged viral suppression. Exogenous
IL-15
resulted in augmentation of
HIV
-gag-specific response in 71% of patients, while IL-2 and IL-7 had variable effects, augmenting responses in 25% patients. Thus,
HIV
-specific CD8 T-cell responses are dependent on both CD4 T-cell help and antigenic stimulation. The cytokine
IL-15
may be a useful modality as adjunctive therapy to augment
HIV
-specific memory CD8 T cells.
...
PMID:Determinants of HIV-specific CD8 T-cell responses in HIV-infected pediatric patients and enhancement of HIV-gag-specific responses with exogenous IL-15. 1273 48
We measured apoptosis of subsets of T lymphocytes by single-cell analysis of caspase activation, to confirm high turnover of chemokine receptor CCR5(+) T cells in subjects with acute, primary human immunodeficiency virus type 1 (HIV-1) infection (PHI). High levels of spontaneous apoptosis, consisting mainly of CD8(+) T lymphocytes, were closely associated with increases in the activation markers Ki-67, CD38, and the
HIV
coreceptor CCR5 and with decreases in Bcl-2 and the interleukin (IL)-7 receptor at the single-cell level. Increased expression of Ki-67 and CCR5 ex vivo, as well as increased apoptosis, was seen in all T cell receptor beta-chain variable region (TCRBV) subfamilies studied. The addition of IL-2 or
IL-15
, but not IL-7, significantly inhibited caspase activation, increased Bcl-2 expression, and rapidly initiated proliferation in vitro of CD8(+) T cells expressing CCR5 and multiple TCRBV subfamilies. Furthermore,
IL-15
receptor alpha-chain messenger RNA levels were increased in peripheral blood mononuclear cells during PHI. These results suggest that CCR5(+)Ki-67(+)Bcl-2(dim) activated T cells generated during PHI traffic via blood to tissue sites, where the cells may survive and/or further proliferate under the local influence of IL-2 or
IL-15
. Understanding cytokine effects on CCR5(+) T cells will be important in understanding chronic
HIV
-1 replication and pathogenesis.
...
PMID:Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2. 1275 Oct 31
IL-15
is essential for the development and differentiation of NK cells. It selectively induces proliferation of CD8+ memory T lymphocytes. Despite its importance in both innate and adaptive immune responses, little is known about its production in
HIV
-infected persons. We report here that
IL-15
levels are significantly decreased in the sera of
HIV
-infected/AIDS patients compared to control sera. We also show that PBMC from the infected patients are compromised in their ability to respond with enhanced production of
IL-15
upon exposure to HSV-1. The decreased production of
IL-15
occurs despite a comparable increase in
IL-15
mRNA in the PBMC of
HIV
-infected and healthy
HIV
-seronegative donors when exposed to HSV-1. The HSV-stimulated patients' PBMC exhibited less NK activity compared to similarly treated normal PBMC. These results suggest that a compromised ability of PBMC from
HIV
-infected individuals to induce
IL-15
production in response to a viral stimulus may be a reason of their compromised innate and adaptive immunity.
...
PMID:Studies on the production of IL-15 in HIV-infected/AIDS patients. 1275 60
Loss of T cell number and function during
HIV infection
or secondary to pharmacologic immunosuppression renders individuals susceptible to opportunistic infections, including Pneumocystis carinii pneumonia. Because costimulatory receptors are critical for optimal T cell function, we hypothesized that these proteins would regulate susceptibility to opportunistic infections. We found that despite normal T cell numbers, mice deficient in the costimulatory molecules CD2 and CD28 spontaneously developed P. carinii pneumonia. In experiments using intratracheal injection of P. carinii organisms to induce infection, the loss of CD28 alone was sufficient to render mice susceptible to acute infection; however, the organism was eventually cleared. Examination of inflammatory responses to P. carinii revealed that mice deficient in both CD2 and CD28 accumulated CD8(+) T cells in their lungs in response to infection and demonstrated markedly reduced specific Ab titers. Analysis of cytokine profiles suggested that regulation of IL-10 and
IL-15
may be important elements of the response to this pathogen. Thus, costimulatory molecule function is critical in determining the initial susceptibility to infection with P. carinii. Analysis of immunologic responses in these mice may provide important insights into the defects that render individuals susceptible to opportunistic infection, and provide opportunities for novel immunologically based therapies.
...
PMID:T cell costimulatory molecule function determines susceptibility to infection with Pneumocystis carinii in mice. 1290
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>